SHUKRA PHARMACEUTICALS
|
SHUKRA PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹29 Cr | ₹13 Cr | ₹20 Cr | ₹4.44 Cr | ₹1.02 Cr |
| Adjustment | ₹2.82 Cr | ₹2.12 Cr | ₹1.55 Cr | ₹1.60 Cr | ₹1.91 Cr |
| Changes In working Capital | ₹-27 Cr | ₹-3.78 Cr | ₹-26 Cr | ₹-2.62 Cr | ₹5.50 Cr |
| Cash Flow after changes in Working Capital | ₹4.77 Cr | ₹12 Cr | ₹-4.57 Cr | ₹3.42 Cr | ₹8.43 Cr |
| Cash Flow from Operating Activities | ₹3.15 Cr | ₹7.92 Cr | ₹-5.20 Cr | ₹3.17 Cr | ₹7.99 Cr |
| Cash Flow from Investing Activities | ₹-14 Cr | ₹-1.26 Cr | ₹-1.20 Cr | ₹-4.43 Cr | ₹-1.53 Cr |
| Cash Flow from Financing Activities | ₹4.83 Cr | ₹-4.52 Cr | ₹12 Cr | ₹4.94 Cr | ₹-6.68 Cr |
| Net Cash Inflow / Outflow | ₹-6.20 Cr | ₹2.14 Cr | ₹6.01 Cr | ₹3.68 Cr | ₹-0.21 Cr |
| Opening Cash & Cash Equivalents | ₹12 Cr | ₹9.98 Cr | ₹3.97 Cr | ₹0.29 Cr | ₹0.50 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹5.92 Cr | ₹12 Cr | ₹9.98 Cr | ₹3.97 Cr | ₹0.29 Cr |
Compare Cashflow Statement of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹3,316.5 Cr | 9.9% | 24.1% | 86.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 9.9% |
24.1% |
86.2% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses